STX16-NPEPL1
Basic information
Region (hg38): 20:58651434-58715410
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Pseudohypoparathyroidism type 1B (117 variants)
- not provided (64 variants)
- Inborn genetic diseases (35 variants)
- Autosomal dominant pseudohypoaldosteronism type 1 (8 variants)
- not specified (2 variants)
- STX16-related condition (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STX16-NPEPL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 0 | |||||
non coding | 102 | 26 | 70 | 198 | ||
Total | 0 | 0 | 105 | 26 | 72 |
Variants in STX16-NPEPL1
This is a list of pathogenic ClinVar variants found in the STX16-NPEPL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-58651457-G-A | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651473-C-G | Pseudohypoparathyroidism type 1B | Benign (Jan 12, 2018) | ||
20-58651513-G-A | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 12, 2018) | ||
20-58651542-T-G | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 12, 2018) | ||
20-58651543-G-A | Pseudohypoparathyroidism type 1B | Benign (Jul 01, 2022) | ||
20-58651586-C-G | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651598-G-A | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 12, 2018) | ||
20-58651630-G-A | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 13, 2018) | ||
20-58651652-C-T | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651657-C-A | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651847-G-A | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651944-T-C | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651982-A-C | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58652050-A-G | Inborn genetic diseases | Uncertain significance (May 25, 2022) | ||
20-58652105-C-T | Likely benign (May 18, 2018) | |||
20-58652106-T-TC | Uncertain significance (Jul 22, 2023) | |||
20-58652112-C-A | Pseudohypoparathyroidism type 1B | Benign/Likely benign (Jun 19, 2022) | ||
20-58652112-C-T | Inborn genetic diseases | Uncertain significance (Jan 22, 2024) | ||
20-58652152-C-A | Likely benign (Jan 16, 2024) | |||
20-58652153-G-A | Pseudohypoparathyroidism type 1B | Benign (Jan 04, 2024) | ||
20-58652371-A-AC | Benign (May 26, 2021) | |||
20-58659426-A-G | Benign (May 16, 2021) | |||
20-58659457-AAAG-A | Benign (May 16, 2021) | |||
20-58659605-G-A | Likely benign (Mar 19, 2022) | |||
20-58659624-A-C | Inborn genetic diseases | Uncertain significance (May 03, 2024) |
GnomAD
Source:
dbNSFP
Source:
Haploinsufficiency Scores
- pHI
- hipred
- hipred_score
- ghis
- 0.515
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene ontology
- Biological process
- intracellular protein transport;vesicle fusion;vesicle docking
- Cellular component
- endomembrane system;integral component of membrane;SNARE complex
- Molecular function
- SNARE binding;SNAP receptor activity